As investors say farewell to a week marked by a Federal Reserve meeting, surprise labor market data and the latest corporate earnings,
Tag: Vertex Pharmaceuticals Inc
CarMax, Nike, Paramount and more
Check out the companies making headlines in midday trading. CarMax — The used vehicle seller tumbled 13% after reporting fourth-quarter earnings of
Sickle cell disease gene therapies Casgevy Lyfgenia insurance cost issues
The approval of two gene therapies to treat sickle cell disease has given hope to patients who suffer from the debilitating disease,
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating patients, some
Cathie Wood’s highest conviction stock picks for 2024
Ark Invest’s Cathie Wood unveiled her highest conviction stock picks for 2024 as she winds down a banner year with her flagship
First CRISPR gene-editing treatment approved in U.S.
The U.S. Food and Drug Administration on Friday approved the country’s first gene-editing treatment, Casgevy, for use in patients with sickle cell
Stocks making the biggest moves after hours: TRIP, CTRA, IFF
Check out the companies making headlines in extended trading. Tripadvisor — The online travel agency added nearly 12% after beating on the
Many strategists see prices higher but earnings lower
I noted last week that there is an unusual divergence in thinking among Wall Street strategists for earnings and prices in 2023.
No More Posts Available.
No more pages to load.